Amneal Pharmaceuticals

(Image: Getty/marchmeena29)

Amneal invests $340m in generics distributor

By Vassia Barba

Amneal announces acquisition of 65.1% majority interest of generics distributing company, AvKARE, boosting its presence in the generics and federal healthcare market.

(Image: Getty/greenleaf123)

FDA greenlights nine Lyrica generics

By Vassia Barba

Nine companies, including Teva, Alembic and Amneal receive US FDA approval for generic versions of Pfizer’s blockbuster Lyrica.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers